InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Oki Mark K, Chief Financial Officer. Director active across 1 company, notably Aytu Biopharma, INC. Aggregated, 2 filings have been published. Activity tracked since 17 January 2022. The latest transaction was disclosed on 17 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
100,000 shares0Common SharesSEC:0001567619-22-001304
100,000 shares0Common SharesSEC:0001567619-22-001304:0
2 of 2 declarations
About Oki Mark K
Oki Mark K is the Chief Financial Officer of AYTU BIOPHARMA, INC. He is responsible for the financial management of the company, including budgeting, financial analysis, and investment management. His expertise is essential in ensuring the financial viability and growth of the company in the biopharmaceutical sector. He plays a key role in financial strategy and decision-making.
